comparemela.com

Latest Breaking News On - Fcpm iii services - Page 4 : comparemela.com

enGene Holdings Inc. (NASDAQ:ENGN) Major Shareholder De Solidarite Des Travai Fonds Sells 47,854 Shares

EnGene Holdings Inc. (NASDAQ:ENGN – Get Free Report) major shareholder De Solidarite Des Travai Fonds sold 47,854 shares of the firm’s stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $15.00, for a total transaction of $717,810.00. Following the completion of the transaction, the insider now directly […]

Leerink-partnrs
Vivo-capital
Securities-exchange-commission
Omega-fund-management
Morgan-stanley
Dgene-inc
Nasdaq
Wells-fargo-company
Fcpm-iii-services
Gene-holdings-inc
Gene-holdings
Get-free-report

enGene Holdings Inc. (NASDAQ:ENGN) Major Shareholder De Solidarite Des Travai Fonds Sells 47,854 Shares

EnGene Holdings Inc. (NASDAQ:ENGN – Get Free Report) major shareholder De Solidarite Des Travai Fonds sold 47,854 shares of the firm’s stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $15.00, for a total transaction of $717,810.00. Following the completion of the transaction, the insider now directly […]

Leerink-partnrs
Vivo-capital
Securities-exchange-commission
Omega-fund-management
Morgan-stanley
Nasdaq
Dgene-inc
Wells-fargo-company
Fcpm-iii-services
Gene-holdings-inc
Gene-holdings
Get-free-report

Short Interest in enGene Holdings Inc. (NASDAQ:ENGN) Expands By 54.9%

EnGene Holdings Inc. (NASDAQ:ENGN – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 12,700 shares, an increase of 54.9% from the March 15th total of 8,200 shares. Based on an average daily volume of 44,900 shares, […]

Leerink-partnrs
Blue-owl-capital-holdings
Morgan-stanley
Nasdaq
Omega-fund-management
Goldman-sachs-group-inc
Gene-company-profile
Fcpm-iii-services
Dgene-inc
Gene-holdings-inc
Gene-holdings
Get-free-report

Achilles Therapeutics (NASDAQ:ACHL) PT Lowered to $6.00

Achilles Therapeutics (NASDAQ:ACHL – Free Report) had its target price reduced by Chardan Capital from $11.00 to $6.00 in a research report released on Friday, Benzinga reports. They currently have a buy rating on the stock. Other research analysts also recently issued reports about the company. Piper Sandler reissued a neutral rating and issued a […]

United-states
America
Piper-sandler
Fcpm-iii-services
Blackrock-inc
Achilles-therapeutics-plc
Citadel-advisors
Renaissance-technologies
Achilles-therapeutics
Free-report
Chardan-capital
Vestal-point-capital

NewAmsterdam Pharma (NASDAQ:NAMS) Sees Unusually-High Trading Volume

NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 136,045 shares changed hands during mid-day trading, a decline of 43% from the previous session’s volume of 239,271 shares.The stock last traded at $23.06 and had previously closed at $23.65. Analyst Ratings Changes Several equities analysts recently weighed in […]

Canada
Newamsterdam-pharma
Jamesn-topper
Louisg-lange
Piper-sandler
Securities-exchange-commission
Scotiabank
Goldman-sachs-group-inc
Newamsterdam-pharma-company
Parkman-healthcare-partners
Fcpm-iii-services
Royal-bank

vimarsana © 2020. All Rights Reserved.